能够通过表面功能化的PEG-b-PPS菌根准器官和损伤特定的纳米载体,用于急性损伤
Boaz Y Bishop1,2,3, Swagat H Sharma2,4, Ratnakar Tiwari1
1Department of Medicine and Division of Nephrology & Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. pinelopi.kapitsinou@northwestern.edu.
Nanoscale horizons
|October 6, 2025
概括
研究人员开发了双联体细胞,用于在急性损伤 (AKI) 中精确地将纳米药物输送给炎症脏. 这种有针对性的方法增强了药物局部化到受伤的脏组织,最大限度地减少了非目标效应.
科学领域:
- 纳米医学是一种纳米医学.
- 脏生理学 脏生理学
- 生物材料是一种生物材料.
背景情况:
- 针对脏疾病的纳米医学的向药物递送面临挑战,特别是在炎症脏环境中.
- 现有的策略通常依赖于被动积累或管管特异性连接体,限制了急性损伤 (AKI) 等复杂疾病的疗效.
- 炎症和血管功能障碍是AKI的关键,但脏管外的向尚未得到充分探索.
研究的目的:
- 为了改造双联结体细胞,以增强纳米载体局部化到炎症脏在AKI.
- 同时针对器官特异性和损伤特异性线索,以提高传递精度.
- 在AKI中开发一个模块化和可扩展的纳米医学平台.
主要方法:
- 聚乙烯甘醇-块-聚乙烯硫化物 (PEG-b-PPS) 菌根被偏好性 (CLPVASC) 和炎症内皮结合性 (CYNTTTHRC) 联体功能化.
- 脂质固的类两被用于模块化表面功能化,而不会改变菌根的特性.
- 在体外研究中评估了在低氧-重氧化下内皮细胞的微粒吸收.
- 在体内研究评估了小鼠单边缺血-再输损伤 (IRI) 后脏中的小胞积累.
主要成果:
- 双重向的菌体在体外显示了被压力内皮细胞增强的吸收.
- 在体内,在IRI后,向细胞在受损脏中选择性地积累,优于非向对照.
- 对肝脏,肺部和脏等器官的非目标分布显著减少.
- 双联结子策略在准炎症脏组织方面表现出空间精度.
结论:
- 双结合体菌提供了一个精确而有效的策略,用于将纳米载体输送到AKI的炎症脏.
- 这种模块化平台提高了目标准确性,减少了目标之外的积累,提高了治疗潜力.
- 该方法具有可扩展性和生物信息,适用于AKI和其他炎症状况.
相关概念视频
01:29Acute Kidney Injury II: Pathophysiology
890
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
890
01:22Acute Kidney Injury I: Introduction
572
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
572
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
260
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260
01:20Acute Kidney Injury V: Interprofessional Care
296
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
296
01:22Acute Kidney Injury VI: Nursing Management
384
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
384
01:29Acute Kidney Injury III: Clinical Manifestations
817
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
817